Neil Dahiya

EMA Panel Endorses Palforzia Indication Expansion for Toddler Peanut Allergy Treatment

Stallergenes Greer, a firm dedicated to allergen immunotherapy (AIT) solutions, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given a favorable opinion for broadening Palforzia’s existing use. This development is directed towards

EMA Panel Endorses Palforzia Indication Expansion for Toddler Peanut Allergy Treatment Read More »